Medical News Home

Neotropix®, Inc., a clinical-stage development company focused on neuroendocrine cancer treatments, announced today exciting data from an extensive pediatric preclinical study performed by the National Cancer Institute (NCI) funded Pediatric Preclinical Testing Program on the use of NTX-010 (Seneca Valley Virus-001), a tumor-selective naturally-occurring oncolytic virus.

Boehringer Ingelheim’s most promising new cell cycle kinase inhibitor and potentially first-in-class compound, BI 6727, has shown encouraging results in a phase I clinical trial in patients with advanced tumours who have failed to respond to other treatments.

Inflammation, a frontline defense against infection or disease, can help nurture skin cancer, researchers have found. IDO, an enzyme that works like a firefighter to keep inflammation under control, can be commandeered to protect early malignant cells, say Medical College of Georgia researchers studying an animal model of chronic inflammation and skin cancer.

Today The Women’s Sexual Health Foundation (TWSHF) released an issue of the Women’s Sexual Health Foundation Journal devoted entirely to women’s sexuality and cancer, a topic the Foundation frequently addresses with healthcare professionals, cancer patients and survivors. This journal, entitled Women’s Sexuality and Cancer, is available as a free download on the Foundation’s website, http://www.

A new anti-cancer compound that works by blocking a part of the cell’s machinery that is crucial for cell division has shown promising results in a phase I clinical trial in patients who have failed to respond to other treatments. Now it is going forward into a phase II clinical trial programme.

Scientists have developed a new drug delivery system that is capable of crossing the blood-brain barrier to reach and kill cancer cells in the brain, according to research presented at the 20th EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Geneva today (Wednesday 22 October).

Scientists have developed a new imaging agent that can be used in scanning for tumours, and which gives a much clearer and more precise image than existing methods.

The Garvan Institute of Medical Research and St Vincents & Mater Health Sydney will today announce plans to jointly establish a new $100 million Cancer Centre within the St Vincent’s Research Precinct.

Twenty physicians with the Indiana University School of Medicine have been recognized as the best in their field. The 20 are among 25 in Indiana included in the most recent edition of America’s Top Doctors for Cancer. The current guide identifies the nation’s most outstanding physicians for the diagnosis and treatment of cancers in adults and children.

ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced that three posters describing significant recent results of the company’s proprietary polymer DACH platinum prodrug, ProLindac, in clinical and preclinical studies are being presented this week at a major international oncology conference held in Geneva, Switzerland.